Lucence
Precision oncology company dedicated to creating state-of-the-art, highly sensitive liquid biopsy tests for early disease detection and personalized treatment selection. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD109—164m (Dealroom.co estimates Nov 2019.)
Palo Alto California (HQ)
Authorizing premium user...